Copyright © 2005, European Society of Cardiology
Sodium channels as macromolecular complexes: Implications for inherited arrhythmia syndromes
Department of Pharmacology, The University of Michigan, 1301 MSRB III, Box 0632, 1150 W. Medical Center Dr. Ann Arbor, MI 48109-0632, United States
* Corresponding author. Tel.: +1 734 936 3050; fax: +1 734 763 4450. Email address: lisom{at}umich.edu
Received 10 January 2005; revised 10 March 2005; accepted 7 April 2005
| Abstract |
|---|
|
|
|---|
Mutations in cardiac ion channels and their auxiliary subunits can lead to life-threatening cardiac arrhythmias. In recent years it has become apparent that ion channels are part of large, multi-protein complexes, comprising not only the ion channels and their auxiliary subunits, but also components of the cytoskeleton, regulatory kinases and phosphatases, trafficking proteins, extracellular matrix proteins, and possibly even other ion channels. Disruption of any member of a particular ion channel complex has the potential to disrupt the function of the associated channels, resulting in paroxysmal disease. Understanding the molecular composition of individual ion channel signaling complexes in heart may yield important insights into the molecular basis of cardiac arrhythmias and may suggest novel therapeutic approaches to treatment of these life-threatening conditions.
KEYWORDS Cardiac myocytes; Channel physiology; Sodium channel; Auxilliary subunits; Cell adhesion molecules
| 1. Introduction |
|---|
|
|
|---|
Cardiac action potentials are generated and propagated through the coordinated activity of multiple ion channels, including voltage-gated sodium channels (Nav1s), calcium channels, and potassium channels [1]. Mutations in genes encoding these channels cause familial arrhythmias. Voltage-gated ion channels comprise a central ion-conducting pore associated with one or more auxiliary subunits that regulate channel function. The channel pore can be formed by a single protein, as in sodium and calcium channels, or by four identical or nonidentical
-subunits, as in potassium channels, the latter being the source of tremendous molecular diversity. It is now clear that ion channels do not exist in isolation in vivo but instead associate in complex with other plasma membrane, extracellular matrix, and intracellular proteins that participate in cell adhesion, cytoskeletal anchoring, and signal transduction. The molecular composition of a particular complex can have significant influence on channel function and localization and consequently on cellular excitability. A given channel pore-forming subunit may behave very differently depending on its associated proteins. Thus, the formation of various channel complexes is predicted to be the source of significant functional diversity. A major challenge to our field is to determine the molecular organization of ion channel signaling complexes in functional microdomains of excitable cells, e.g. t-tubules or intercalated disks of cardiac myocytes. We predict that the molecular composition of channel signaling complexes is tissue-specific and even subcellular domain-specific within a given cell type, resulting in localized differences in channel physiology.
In this review, we will focus on the molecular composition of cardiac Nav1 complexes. Nav β-subunits, in addition to modulating channel gating and voltage-dependence, function as molecular scaffolds to bring other proteins to the channel, resulting in the formation of macromolecular complexes and differential regulation of excitability. In addition, Nav1
-subunits participate in protein–protein interactions that are β-subunit independent. Because we currently have a more complete understanding of Nav1 signaling complexes in neurons compared to cardiac myocytes, we will begin with examples of proteins associated with neuronal Nav1s and then discuss those data in terms of cardiac Nav1s, cardiac potassium channels, and future lines of investigation in cardiovascular medicine.
2. Nav1s are composed of – and β-subunits
|
|---|
|
|
|---|
Nav1s are responsible for action potential conduction and propagation in excitable cells [2]. Nav1s isolated from mammalian neurons and cardiac myocytes are multimeric proteins composed of single, pore-forming
-subunit and one or more β-subunits [2]. In neurons, Nav1s are clustered at high density at nodes of Ranvier [3] and are localized at specialized subcellular domains, including axon initial segments, dendrites, and neuronal cell bodies [4], pre- and postsynaptic neuronal membranes [5–7], and the neuromuscular junction [8]. In heart, Nav1s are located at intercalated disks, at the cell surface, at the t-tubules, and in the sinoatrial (SA) node [9–12].
The mammalian pore-forming
-subunits encode a gene family of at least nine members (SCN1A–SCN11A) [13]. A number of excellent reviews are available that provide detailed information on
-subunit structure, function, gene expression, and roles in inherited disease [4,14–20]. While some tissue specificity of Nav1 gene expression exists, traditional ideas of "brain" vs. "heart" Nav1s are no longer valid. Especially interesting to the field of cardiovascular research is the identification of TTX-S "brain" channels (Nav1.1, Nav1.3, and Nav1.6) at t-tubules of cardiac myocytes as well as in the SA node [10–12,21]. While the predominant sodium current in isolated cardiac myocytes is TTX-R, TTX-S currents are detectable following activation with β-scorpion toxin CssIV [11]. In addition to cardiac muscle, the TTX-R "heart" channel, Nav1.5, is expressed in the limbic system of the brain [22,23]. These data are summarized in Table 1. It is essential that researchers and physicians consider these data when developing and prescribing new drugs for arrhythmia and epilepsy. It is reasonable to predict that mutations in Nav1.5 known to cause arrhythmia may also lead to neurological disorders. Likewise, mutations in Nav1.1 known to cause epilepsy may also lead to arrhythmia. There are numerous reports describing patients in which, for example, LQT presents as idiopathic epilepsy, or occipital lobe epilepsy also shows a prolonged QT interval [24]. In cases of Sudden Unexplained Death in Epilepsy, cardiac factors are frequently suspected and death is often attributed to increased autonomic stimulation [24]. An alternative explanation in some cases may be expression of a mutant ion channel gene in both brain and heart such that the patient has epilepsy and arrhythmia. Accurate identification of the underlying genetic components for each patient will be essential to designing effective therapies.
|
The Nav β-subunit gene family consists of four members: β1 (SCN1B) [25], β2 (SCN2B) [26], β3 (SCN3B) [27], and β4 (SCN4B) [12]. β1A, a splice variant of SCN1B, is expressed in embryonic brain and adult heart in rat [28]. β1, β1A, β2, β3, and β4 are proteins with type I topology, containing an extracellular amino-terminus, a single transmembrane segment, and an intracellular carboxyl-terminus. All five β-subunits contain a single, extracellular, immunoglobulin (Ig) domain that is structurally homologous to the V-set of the Ig superfamily and often found in cell adhesion molecules (CAMs) [27,29,30]. This unique property was first discovered for β2, revealing that its extracellular domain contains an Ig-fold and an extended region with similarity to the CAM contactin [26,29]. The extracellular domains of β1/β1A, and β3 show a similar homology to the CAM myelin Po [27,31]. Analysis of the β4 extracellular domain reveals a predicted Ig domain with homology to β2 [30].
-Subunit cDNAs express functional Nav1s in heterologous expression systems such as Xenopus oocytes or mammalian fibroblasts. However, for TTX-S
-subunits, the currents characteristic of these channels expressed in isolation are quite different from native currents. Co-expression of the β-subunits with these channels results in cell type-specific shifts in the voltage-dependence of activation and inactivation, changes in channel modal gating behavior resulting in altered rates of activation, inactivation and recovery from inactivation [32], and increased channel expression at the plasma membrane [33]. β1-mediated effects on TTX-R Nav1.5 channels, however, remain controversial [10,34–36]. In contrast to TTX-S channels, expression of Nav1.5 in oocytes produces channels that inactivate rapidly in the absence of β-subunits [37]. According to some reports, β1 has no observable effect on Nav1.5 function [38,39]. Other groups have reported that coexpression of β1 and Nav1.5 results in increased current density with no detectable effects on channel kinetics or voltage-dependence [37,40]. Some groups have reported modulation of channel sensitivity to lidocaine block with subtle changes in channel kinetics and gating properties in response to β1 expression [41], while others have reported significant shifts in the voltage-dependence of steady-state inactivation [10,42,43] or the rate of recovery from inactivation [43,44]. Scn1b null mice provide a unique opportunity to resolve this controversy by investigating the result of β1 deletion on TTX-R sodium currents in heart [61]. Coexpression of Nav1.5 with β3 in one study resulted in increased current density, depolarizing shifts in the voltage-dependence of inactivation, and increased rate of recovery from inactivation [44] yet, in another study, produced hyperpolarizing shifts in inactivation and slowed recovery from inactivation [43]. Coexpression of β2 [10] or β4 [30] with Nav1.5 resulted in no obvious effects over
alone, suggesting that these β-subunits may not affect the function of Nav1.5. Alternatively, β2 and β4 may require the presence of other proteins that are not present in fibroblasts or oocytes to modify sodium currents. It is important to consider that it may be impossible to properly reconstitute in vivo Nav1 signaling complexes in heterologous expression systems. Because Nav β-subunits bring critical signaling molecules to the channel pore in vivo, one must take care to avoid over-interpretation of in vitro studies of β-subunit-mediated channel modulation.
All five β-subunits are expressed in juvenile and/or adult heart in rodents and are differentially localized to specialized subcellular domains and cell types: β1 and β2 are localized at both t-tubules/Z-lines and intercalated disks in ventricular myocytes [10,45,46], β1A localizes to the myocyte surface [28], β3 colocalizes with β1 at the t-tubules/Z-lines [21], and β4 colocalizes with β2 at the intercalated disks [21]. In addition, β1, β2, β3, and β4 are colocalized with Nav1.1 and Nav1.3 in SA nodal cells where they may contribute to automaticity [12]. β1 and β2 associate with Nav1.1 and with Nav1.5 in ventricular myocytes as assessed by coimmunoprecipitation [10,45]. Very little is known about cardiac Nav
- and β-subunit trafficking in vivo. A study using over-expression of fluorescent-tagged Nav1.5, β1, and β2 in HEK293 cells suggested that Nav1.5 and β2 are transported separately to the plasma membrane while Nav1.5 and β1 form a complex in the endoplasmic reticulum that may facilitate plasma membrane trafficking [47]. Nav1.5 cell surface density is regulated by Nedd4-2 ubiquitination [48–50]. The availability of mouse models will now allow these ideas to be tested in vivo.
The observation that β4 is expressed in heart may lead to important new advances in the understanding of the regulation of cardiac sodium currents by auxiliary subunits. β4 may serve as the endogenous open-channel blocker that generates resurgent sodium current [51]. While resurgent sodium current in cardiac myocytes has not yet been reported, this information may lead to important new insights into the molecular basis of cardiac excitability and arrhythmia. Finally, a recent study showed β1 mRNA and protein expression in embryonic mouse heart [46]. Thus, Nav β-subunits may have effects on embryonic cardiac development as well as on postnatal electrical excitability.
| 3. Nav1 function in vivo |
|---|
|
|
|---|
In heterologous systems, even in the presence of β-subunits, sodium currents expressed by the various SCN genes are difficult to distinguish from one another, suggesting that these channels might have some overlapping functions in vivo. However, studies with genetically engineered null mice clearly show that this is not the case. In most situations, the loss of expression of a single SCN gene, or even reduced gene expression, results in a severe phenotype, demonstrating that each SCN gene product has specialized functions that cannot be compensated by overexpression of one of the remaining SCN genes. Scn1a null mice display motor deficits, ataxia, and seizures with lethality by postnatal day 16 [52]. Scn1a heterozygotes also exhibit a dramatic seizure phenotype that is frequently lethal. This phenotype is remarkably similar to Severe Myoclonic Epilepsy of Infancy caused by truncation mutations in SCN1A that result in its haploinsufficiency [53]. The cardiac phenotype of these mice has not yet been reported. Targeted disruption of Scn5a causes intrauterine lethality with severe deficits in ventricular morphogenesis [54]. Scn5a heterozygotes show normal survival but have several deficits, including impaired atrioventricular conduction, delayed intramyocardial conduction, increased ventricular refractoriness, and ventricular tachycardia with characteristics of reentrant excitation [54]. Null mutations of Scn8a result in ataxia, tremor, and progressive paralysis with lethality by 3 weeks of age [55]. The cardiac phenotype of these mice is not yet known. The hypomorphic allele Scn8amedJ reduces Scn8a mRNA and protein to 10% of normal levels [56]. Scn8amedJ/medJ homozygotes exhibit ataxia and tremor and develop a progressive dystonic phenotype that resembles primary torsional dystonia in humans [57,58].
| 4. Nav1 signaling complexes |
|---|
|
|
|---|
Obviously, the critical difference between in vitro and in vivo studies is channel expression in native cells. In their native environment, Nav1s are targeted to specialized subcellular domains where they associate with specific signaling and structural proteins, and where they are exposed to second messengers in a regulated fashion. For example, in heart, Nav1s are differentially localized to t-tubules/Z-lines, intercalated disks, and SA node [9–12,21,45]. To make this situation even more complex, Nav1.5 colocalizes with β-adrenergic receptors and G-proteins to caveoli in heart [59]. Recreating each individual situation in a heterologous system is nearly impossible, thus limiting our ability to interpret in vitro results in terms of in vivo physiology. If it were possible to exactly recreate these macromolecular complexes in vitro, then we would likely find that a given Nav1
-subunit behaves very differently depending on the molecular composition of the signaling complex. As explained in the following section, we predict that β-subunits play critical roles in the formation of Nav1 signaling complexes in vivo.
4.1. β-subunits are key players in Nav1 signaling complexes
β-subunits do not form the ion-conducting pore, but are multifunctional proteins that play critical roles in modulation of channel function, regulation of channel expression levels at the plasma membrane, and cell adhesion [32]. This feature makes Nav1s unique among the superfamily of voltage- and ligand-gated ion channels. In vitro evidence suggests that β-subunits serve as critical communication links between adjacent cells, the extracellular environment, and intracellular signaling mechanisms, possibly including other ion channels, in Nav1 complexes. The availability of β1 and β2 null mice now allows this novel hypothesis to be tested in vivo [60,61].
β1 and β2 have functional roles in addition to modulation of channel function in vitro [62]. β1 and/or β2 interact with the extracellular matrix molecules tenascin-C and tenascin-R [63,64], proteins that are expressed in both brain and heart [65,66]. β1 and β2 participate in homophilic cell adhesion, resulting in cellular aggregation and recruitment of the cytoskeletal anchoring protein ankyrin to the plasma membrane at sites of cell–cell contact [67]. AnkyrinB and ankyrinG are expressed in both brain and heart and are critical to the regulation of electrical excitability [68–72]. β1 and β2 associate with ankyrinG [45,67,73,74] and ankyrinB [45]. β1-ankyrin interactions are regulated by phosphorylation of β1Y181, located in the carboxyl-terminus [73], resulting in its differential localization in cardiac myocytes [45]. β1Y181E, a mutant that does not interact with ankyrin, also does not modulate Nav1 function despite efficient association with
, suggesting that regions of the β1 intracellular domain are critical for channel modulation as well as cytoskeletal association [74]. β1 associates with the cardiac intercalated disk proteins N-cadherin and connexin-43 [45]. β1 also interacts with other CAMs found at the node of Ranvier, paranode, and axon initial segment, including contactin, Nav β2, neurofascin-186, neurofascin-155, and NrCAM [74–80]. The interaction of β1 with contactin or neurofascin-186 results in significant increases in channel cell surface expression. Cardiac β-subunit-interacting Ig-CAMs have not yet been identified. NCAM is expressed at intercalated disks in heart and is upregulated in myocardial ischemia and in Chagas' disease myocarditis [81,82]. Thus, it is a candidate for β1 interaction in heart. Finally, β1 associates with the intracellular phosphatase domain of receptor phosphotyrosine phosphatase β [83], potentially providing a mechanism for regulated tyrosine phosphorylation.
β1, in particular, appears to be essential for the interaction of Nav1s with multiple CAMs and cytoskeletal proteins in vitro and in vivo [61,74–76]. β1-mediated cell adhesive and cytoskeletal interactions occur in the presence or absence of the pore-forming
-subunit. In the presence of
, some β1-mediated cell adhesive and cytoskeletal association events ultimately result in changes in channel activity in vitro [64,74,84]. We propose that β1-subunits act as molecular scaffolds to bring cytoskeletal, cell adhesion, and signaling molecules to the ion conducting pore, thus affecting channel function, channel subcellular localization, and channel cell surface expression in a cell-specific or subcellular domain-specific manner.
4.2. What does this mean in terms of cardiovascular physiology?
Previous work from our laboratory and others has made significant contributions to the understanding of Nav1 signaling complexes in neurons. Do similar interactions occur between Nav β1-subunits, extracellular matrix, cell adhesion, and cytoskeletal proteins in heart? While we have less information on the identities of cardiac specific Nav1 interacting proteins, the answer is yes. Nav1s form macromolecular complexes in heart as they do in brain. More interestingly, while some of the proteins involved in Nav1 complexes may be similar in brain and heart, e.g. ankyrin and tenascin, we predict that many proteins will be specific to particular myocyte subcellular domains, e.g. connexin-43.
Tyrosine phosphorylation of the intracellular domain of some Ig-CAMs abolishes their ability to interact with ankyrin, establishing specialized microdomains in polarized cells [85–88]. For example, non-phosphorylated neurofascin interacts with ankyrinG at nodes of Ranvier while tyrosine-phosphorylated CAMs in the same gene family are found at other specialized sites of cell–cell contact such as paranodes, neuromuscular junctions, adherens junctions, and regions of neuronal migration and axon extension [85,89]. Similarly, tyrosine-phosphorylated β1 (pYβ1) and non-phosphorylated β1 are differentially localized to specific subcellular domains (intercalated disks vs. t-tubules/Z-lines, respectively) in cardiac myocytes where they interact with different cytoskeletal and signaling proteins [45].
TTX-S and TTX-R Nav1s are differentially localized to t-tubules/Z-lines and intercalated disks, respectively, in cardiac myocytes [10,11] (Fig. 1). The TTX-S channels Nav1.1, Nav1.3, and Nav1.6 localize to t-tubules/Z-lines, while TTX-R Nav1.5 is found at intercalated disks. Points made by Brette and Orchard [90], however, are well taken: immunolocalization of Nav
- and β-subunits at Z-lines does not automatically imply t-tubule function. In addition, if Nav1s are located at the t-tubules, they may be restricted to specialized subdomains that are separate from the calcium channel-containing dyad. It is clear that additional work is required to investigate these issues. pYβ1 colocalizes with connexin-43, N-cadherin, and Nav1.5 at intercalated disks but is not detected at the t-tubules/Z-lines. An antibody that does not differentiate between the phosphorylated and non-phosphorylated forms of β1 stains both intercalated disks and t-tubules/Z-lines. Anti-pYβ1 immunoprecipitates N-cadherin from heart membranes and from cells transfected with β1 and N-cadherin in the absence of other Nav subunits. pYβ1 does not associate with ankyrinB in heart membranes while ankyrinB associates with an immune complex precipitated using the non-discriminating β1 antibody. N-cadherin and connexin-43 associate with β1 and with Nav1.5 in heart membranes. These results suggest that Nav1 complexes at intercalated disks of ventricular myocytes are composed of Nav1.5 and pYβ1 in close association with both N-cadherin and connexin-43, while non-phosphorylated β1, ankyrinB, and TTX-S Nav1s are associated at t-tubules/Z-lines. β1 phosphorylation appears to regulate its localization to differential subcellular domains in myocytes and thus its availability to associate with differential signaling molecules.
|
In adult heart, cardiomyocytes are linked together at intercalated disks, where adherens junctions, gap junctions, and desmosomes make up the cardiac intercellular junctions that mediate mechanical and electrical coupling throughout the heart [91]. A close association of adherens junctions with mechanical junctions at the intercalated disks is necessary for conduction, and expression of N-cadherin at adherens junctions is a prerequisite for subsequent gap junction formation [92,93]. Our results demonstrate that pYβ1 interacts with Nav1.5 and N-cadherin, an adherens junctional protein, at intercalated disks and that the Nav1.5 signaling complex also associates with connexin-43, a gap junctional protein. The intracellular domain of cadherin interacts with the catenins, proteins that ultimately communicate with the actin cytoskeleton and play roles in the regulation of cell adhesion and intracellular signaling [94]. Disruption of the F-actin based and microtubular cytoskeleton in myocytes modulates the coupling between availability and activation of cardiac Nav1s, suggesting that cytoskeletal integrity may be a requirement for normal propagation of cardiac action potentials and thus regulation of excitability [95,96]. In addition to N-cadherin, pYβ1 may interact with cytoskeletal anchoring proteins located at intercalated disks such as the PDZ domain containing molecule syntrophin-
2, which also interacts with Nav1.5 [97], or ZO-1, a PDZ-domain containing molecule that associates with connexin-43 [98,99].
Intracellular interactions between β1 and ankyrin are critical for channel cell surface expression as well as for β1-mediated modulation of channel function in vitro [74]. This has been postulated to be especially critical for Nav1.5 [100]. The significance of these interactions is illustrated by a study characterizing a mutation in SCN1A identified in a family with dominantly inherited Generalized Epilepsy with Febrile Seizures Plus (GEFS+2, OMIM 604233
[OMIM]
) [101]. The mutation, D1866Y, located in the carboxyl-terminal domain of Nav1.1, decreases modulation of
by β1. Direct interaction between the carboxyl-terminal domains of wild-type
and β1 was demonstrated by yeast two-hybrid and coimmunoprecipitation analyses. The D1866Y mutation weakened this interaction, strengthening the hypothesis that the β1 intracellular domain is critical for channel modulation, and demonstrating a novel molecular mechanism leading to seizure susceptibility. Nav1.1 is expressed in heart as well as in brain [10]. Thus, mutations in this channel that are known to lead to epilepsy may also be responsible for generating cardiac arrhythmias.
| 5. Nav β-subunits and arrhythmias |
|---|
|
|
|---|
Because β-subunits are critical for maintaining channel association with cell adhesion, signal transduction, and cytoskeletal molecules in vitro, we predict that mutations in β-subunit genes may lead to human disease. Although several mutations in Nav1
–subunits have been associated with inherited diseases, including epilepsy (SCN1A, SCN2A), skeletal muscle myopathies (SCN4A), LQT and Brugada Syndromes (SCN5A), and erythermalgia (SCN9A) [1,102,103], to date only one human disease has been associated with a gene encoding a Nav β-subunit. A mutation (C121W) in the extracellular Ig domain of β1 (SCN1B) causes generalized epilepsy with febrile seizures (GEFS+1) (OMIM 604233
[OMIM]
) [104]. Similarly, a five amino acid deletion in the Ig domain of β1 was found in a family with febrile seizures and early onset absence epilepsy [105]. Compared to wild-type β1, β1C121W increases the fraction of available Nav1s at resting membrane potentials and reduces sodium current rundown during high frequency channel activity [84]. The β1C121W mutation also disrupts β1–β1 cell adhesion. These potential effects on channel gating and cell adhesion in vivo may bias cells toward hyperexcitability. β1 is expressed in myocytes as well as in neurons [25]. Although GEFS+1 individuals manifest a clear neuronal phenotype, defects in cardiac function have not been investigated. Examination of the ECG of GEFS+1 individuals may yet reveal abnormalities in cardiac function resulting from the presence of this mutant β-subunit.
The predominant Nav1 in cardiac tissue is Nav1.5 and many mutations in SCN5A result in LQT-3 (OMIM 603830
[OMIM]
) or Brugada (OMIM 601144
[OMIM]
) syndromes [19]. Brugda syndrome has been proposed to be caused by a reduction in the number of functional Nav1s leading to decreased sodium conductance in the myocardium. Interestingly, β1 may play a role in this disease. This is illustrated by a study investigating functional expression in HEK cells of a double mutant underlying idiopathic ventricular fibrillation characterized by ST-segment elevation (Nav1.5-R1232W/T1620M) [106]. Expression of the mutant
-subunit alone resulted in robust inward currents, however, coexpression of the mutant
with wild-type β1 resulted in a four-fold reduction in current density and a corresponding decrease in
-subunit protein expression. Thus, loss of function caused by the mutation in
was dependent on the presence of β1. The authors proposed that the addition of β1 results in formation of a mutant
–β complex with reduced stability.
A particularly interesting LQT mutation is Nav1.5-D1790G that disrupts the ability of Nav1.5 to be modulated by β1 [107]. D1790G is located in the carboxyl-terminus of Nav1.5, similar to Nav1.1-D1866Y that also disrupts
–β1 association [101]. Another LQT mutation in the carboxyl-terminus of Nav1.5 (Nav1.5-E1784K) results in a defect in fast inactivation characterized by a small, persistent current during long membrane depolarizations [108]. Coexpression of this mutant channel with β1 results in an exaggeration of the shifts in the voltage dependence of steady-state inactivation. All three of these mutations support the hypothesis that the carboxyl-terminus of β1 is critical for channel modulation in vivo. Because the intracellular domain of β1 is critical for Nav1-ankyrin interactions as well as channel modulation in vitro [74,100], we predict that diseases resulting from these mutations are a consequence of disrupted channel-cytoskeletal interactions in addition to altered channel electrophysiological behavior. It is not known whether Nav1.1-D1866Y and/or Nav1.5-D1790G completely abolish
–β1 association, as extracellular
–β1 sites of interaction have been identified [109,110]. However, if so, then channel association with other molecules that require β1 may be abolished as well. β1 null mice [61] exhibit a significantly lengthened QT interval compared to their wild-type littermates [111]. Together, these observations suggest that mutations resulting in loss of β1 expression may result in disruption of normal cardiac Nav1 function. It remains to be seen whether mutations in β1, or indeed any Nav β-subunit, can result in arrhythmia or other cardiac disorders in humans.
| 6. Cardiac multi-ion channel complexes? |
|---|
|
|
|---|
It is clear that cardiac ion channels participate in complexes with cytoskeletal, signal transduction, and extracellular matrix proteins. Is it possible that multiple ion channels associate in the same complex? Nav1s and voltage-gated potassium channels (Kvs) may physically associate in heart. Kv4.3 contributes to transient outward current (Ito) in the human ventricle [1,112]. Interestingly, Kv4.3 can be modulated by coexpression of Nav β1, resulting in increased current density, shifts in the voltage-dependence of inactivation, and altered channel kinetics [113]. Inhibition of β1 transcription in ventricular myocytes results in the reduction of mRNA and/or protein levels of Nav1.5, Kv4.2, Kv4.3, and KChIP2, a calcium-binding accessory subunit that modulates Kv4-encoded currents [114]. The observed reductions in Nav1 and Kv protein levels were consistent with functional reductions in both INa and Ito. These data agree with previous studies in which inhibition of KChIP2 transcription resulted in reductions of INa and Ito, reductions in Nav1.5 and β1 mRNA levels, and reductions in Kv4.2 and Kv4.3 protein [115]. Coimmunoprecipitation studies revealed association of Kv4.2 or Kv4.3 with β1 in ventricular myocardium [114]. Together, these intriguing observations suggest that cardiac Nav1.5 may physically associate with Ito channels via β1 and KChIP2 to form a macromolecular complex.
| 7. Other Nav1 molecular interactions |
|---|
|
|
|---|
A number of key Nav1 molecular interactions are dependent on the presence of β-subunits. However, this is not the complete story. There are multiple proteins that interact directly with Nav1
-subunits in heart, independent of β.
7.1. Ankyrins
Nav1
-subunits interact indirectly with ankyrin via β-subunits [73]. Nav1s also interact directly with ankyrinG via a conserved 9-amino acid motif located within LII–III [116]. The Nav1.5-E1053K mutation associated with Brugada syndrome is localized to the LII–III ankyrin-binding motif [117]. This mutation disrupts the association of Nav1.5 with ankyrinG, resulting in decreased channel cell surface expression. These data suggest that the interaction of Nav1.5 with ankyrinG is critical to the proper localization of Nav1.5 in cardiomyocytes, as it is for Nav1 localization to the initial segments of CNS axons [71]. Nav1.5-E1053K channels also exhibit shifts in voltage-dependence and altered gating kinetics, suggesting that interaction of Nav1.5 with ankyrinG modulates channel function in addition to localization.
Of the seven gene loci associated with LQT, six encode ion channel subunits, while LQT-4 (OMIM 106410 [OMIM] ) results from mutations in ankyrinB [1,68]. In cardiac myocytes, ankyrinB is localized to the t-tubules. Mice heterozygous for the ankyrinB null allele exhibit a similar LQT phenotype to humans, with reduced t-tubular localization of the inositol-1,4,5-triphosphate receptor, Na+/Ca2+exchanger, and Na+/K+ATPase, all of which bind ankyrinB [68]. Calcium signaling in myocytes is severely disrupted, resulting in extrasystoles. Surprisingly, localization and cell surface expression levels of NaV1.5 and Nav1.6 are unaffected [68,117]. No significant differences in the cardiac action potential upstroke or duration were detected in ventricular myocytes isolated from ankyrinB heterozygotes compared to their wild-type littermates. In contrast, examination of sodium currents in primary cultures of ankyrinB-null neonatal cardiomyocytes revealed prolonged action potentials and subtle differences in channel kinetics [70], suggesting that, while ankyrinB haploinsufficiency has no observable effects on Nav1s, the complete loss of ankyrinB expression may be required before Nav1 expression and localization are disrupted. Ventricular myocytes express both ankyrinG and ankyrinB. AnkyrinG is localized at both the t-tubules and intercalated discs, with a similar staining pattern to that of Nav1s [117]. In mice heterozygous for the ankyrinB-null mutation, the continued expression of ankyrinG may be sufficient for maintenance of normal Nav1 localization and expression. Generation of mice specifically lacking ankyrinG in heart would allow further examination of the role of ankyrin isoforms in the localization of cardiac Nav1s.
7.2. Syntrophins
Syntrophins are cytoplasmic peripheral membrane proteins of the dystrophin associated protein complex (DAPC) [118] that connect to the actin cytoskeleton. Nav1.5 copurifies with syntrophins and dystrophin in mouse, suggesting that this channel may interact with the cytoskeleton independent of, or in addition to, ankyrin binding [119].
1-, β1-, and β2-syntrophin contain PDZ-domains that bind to the carboxyl-terminus of Nav1.5. A similar PDZ binding motif is located at the carboxyl-termini of a number of inward rectifier potassium channels, including Kir2.1, Kir2.2, Kir2.3, and Kir4.1 [120]. Kir2 and Kir4.1 interact via their PDZ-binding motifs with components of DAPC (including
1-, β1-, and β2-syntrophin, dystrophin, and dystrobrevin) in heart. Interaction of sodium or potassium channels with dystrophin via syntrophin may contribute to channel localization, as has been proposed for the interaction of Nav1s with ankyrin [85]. Channel function may also be modulated by syntrophin binding: the carboxyl-terminus of Kv1.1 contains the SXV sequence and the interaction of this region with the cytoskeleton regulates the degree of modulation by Kv β-subunit [85].
| 8. Summary |
|---|
|
|
|---|
Cardiac action potentials are formed from the coordinated activation of multiple ion channels whose function and localization are tightly regulated. Altered or loss of function of any of these channels can disrupt action potential conduction, resulting in desynchronization and arrhythmia. Ion channel pore-forming
-subunits associate with β-subunits that regulate their expression and function. We now know that ion channels also interact with multiple signaling proteins, including cytoskeletal molecules, regulatory kinases and phosphatases, components of cellular trafficking, and extracellular matrix molecules, as part of large, multi-protein complexes. β-subunits appear to play key roles in this intermolecular communication. We propose that proper formation of channel protein–protein interactions is critical to channel function and localization and thus to cellular excitability in vivo. In the past, enormous progress has been made toward understanding the molecular basis of ion channel structure and function. These experiments necessarily made use of heterologous expression systems, in which channels could be studied in isolation, and thus precluded the identification of cell-specific regulatory and structural interacting proteins that are critical to the modulation of cellular excitability in vivo. It is now essential that we understand how ion channels function as members of cell-specific, multi-protein complexes and how disruption of a particular complex can lead to disease. To accomplish this goal, it is necessary to study channels in their native cellular environments. Tissue-specific gene targeting experiments, especially those utilizing inducible promoters, are currently the gold standard for the study of in vivo functioning of ion channel complexes. Understanding the molecular composition of ion channel complexes in specific subcellular domains will be critical to the future development of innovative and effective therapies to treat cardiac arrhythmias.
| Notes |
|---|
Time for primary review 26 days
| References |
|---|
|
|
|---|
- Roden D.M., Balser J.R., George A.L. Jr., Anderson M.E. Cardiac ion channels. Annu Rev Physiol (2002) 64:431–475.[CrossRef][Web of Science][Medline]
- Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron (2000) 26:13–25.[CrossRef][Web of Science][Medline]
- Poliak S., Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci (2003) 4:968–980.[Web of Science][Medline]
- Trimmer J.S., Rhodes K.J. Localization of voltage-gated ion channels in mammalian brain. Annu Rev Physiol (2004) 66:477–519.[CrossRef][Web of Science][Medline]
- Krueger B.K., Blaustein M.P. Sodium channels in presynaptic nerve terminals. J Gen Physiol (1980) 76:287–313.
[Abstract/Free Full Text] - Lipowsky R., Gillessen T., Alzheimer C. Dendritic Na+ channels amplify EPSPs in hippocampal CA1 pyramidal cells. J Neurophysiol (1996) 76:2181–2191.
[Abstract/Free Full Text] - Caldwell J.H., Schaller K.L., Lasher R.S., Peles E., Levinson S.R. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci U S A (2000) 97:5616–5620.
[Abstract/Free Full Text] - Bailey S.J., Stocksley M.A., Buckel A., Young C., Slater C.R. Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats. J Neurosci (2003) 23:2102–2111.
[Abstract/Free Full Text] - Cohen S.A. Immunocytochemical localization of rH1 sodium channel in adult rat heart atria and ventricle. Presence in terminal intercalated disks. Circulation (1996) 94:3083–3086.
[Abstract/Free Full Text] - Malhotra J.D., Chen C., Rivolta I., Abriel H., Malhotra R., Mattei L.N., et al. Characterization of sodium channel
and β subunits in rat and mouse cardiac myocytes. Circulation (2001) 103:1303–1310.[Abstract/Free Full Text] - Maier S.K., Westenbroek R.E., Schenkman K.A., Feigl E.O., Scheuer T., Catterall W.A. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci U S A (2002) 99:4073–4078.
[Abstract/Free Full Text] - Maier S.K., Westenbroek R.E., Yamanushi T.T., Dobrzynski H., Boyett M.R., Catterall W.A., et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A (2003) 100:3507–3512.
[Abstract/Free Full Text] - Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., et al. Nomenclature of voltage-gated sodium channels. Neuron (2000) 28:365–368.[CrossRef][Web of Science][Medline]
- Viswanathan P.C., Balser J.R. Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med (2004) 14:28–35.[CrossRef][Web of Science][Medline]
- Robinson R., Gardiner M. Molecular basis of Mendelian idiopathic epilepsies. Ann Med (2004) 36:89–97.[CrossRef][Web of Science][Medline]
- Lai J., Porreca F., Hunter J.C., Gold M.S. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol (2004) 44:371–397.[CrossRef][Web of Science][Medline]
- Yu F.H., Catterall W.A. Overview of the voltage-gated sodium channel family. Genome Biol (2003) 4:207.[CrossRef][Medline]
- Tan H.L., Bezzina C.R., Smits J.P., Verkerk A.O., Wilde A.A. Genetic control of sodium channel function. Cardiovasc Res (2003) 57:961–973.
[Abstract/Free Full Text] - Liu H., Clancy C., Cormier J., Kass R. Mutations in cardiac sodium channels: clinical implications. Am J Pharmacogenomics (2003) 3:173–179.[CrossRef][Medline]
- Plummer N.W., Meisler M.H. Evolution and diversity of mammalian sodium channel genes. Genomics (1999) 57:323–331.[CrossRef][Web of Science][Medline]
- Maier S.K., Westenbroek R.E., McCormick K.A., Curtis R., Scheuer T., Catterall W.A. Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart. Circulation (2004) 109:1421–1427.
[Abstract/Free Full Text] - Hartmann H.A., Colom L.V., Sutherland M.L., Noebels J.L. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nature (1999) 2:593–595.
- Wu L., Nishiyama K., Hollyfield J.G., Wang Q. Localization of Nav1.5 sodium channel protein in the mouse brain. Neuroreport (2002) 13:2547–2551.[CrossRef][Web of Science][Medline]
- Britton J. Syncope and seizures. Differential diagnosis and evaluation. Clin Auton Res (2004) 14:148–159.[Web of Science][Medline]
- Isom L.L., De Jhong K.S., Patton D.E., Reber B.F.X., Offord J., Charbonneau H., et al. Primary structure and functional expression of the β1 subunit of the rat brain sodium channel. Science (1992) 256:839–842.
[Abstract/Free Full Text] - Isom L.L., Ragsdale D.S., De Jhong K.S., Westenbroek R.E., Reber B.F., Scheuer T., et al. Structure and function of the β2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell (1995) 83:433–442.[CrossRef][Web of Science][Medline]
- Morgan K., Stevens E.B., Shah B., Cox P.J., Dixon A.K., Lee K., et al. 3β: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 97:2308–2313.
[Abstract/Free Full Text] - Kazen-Gillespie K.A., Ragsdale D.S., D'Andrea M.R., Mattei L.N., Rogers K.E., Isom L.L. Cloning, localization, and functional expression of sodium channel β1A subunits. J Biol Chem (2000) 275:1079–1088.
[Abstract/Free Full Text] - Isom L.L., Catterall W.A. Na+ channel subunits and Ig domains. Nature (1996) 383:307–308.[Medline]
- Yu F.H., Westenbroek R.E., Silos-Santiago I., McCormick K.A., Lawson D., Ge P., et al. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci (2003) 23:7577–7585.
[Abstract/Free Full Text] - McCormick K.A., Isom L.L., Ragsdale D., Smith D., Scheuer T., Catterall W.A. Molecular determinants of Na+ channel function in the extracellular domain of the β1 subunit. J Biol Chem (1998) 273:3954–3962.
[Abstract/Free Full Text] - Isom L.L., De Jongh K.S., Catterall W.A. Auxiliary subunits of voltage-gated ion channels. Neuron (1994) 12:1183–1194.[CrossRef][Web of Science][Medline]
- Isom L.L., Scheuer T., Brownstein A.B., Ragsdale D.S., Murphy B.J., Catterall W.A. Functional co-expression of the β1 and type IIA
subunits of sodium channels in a mammalian cell line. J Biol Chem (1995) 270:3306–3312.[Abstract/Free Full Text] - Sangameswaran L., Delgado S.G., Fish L.M., Koch B.D., Jakeman L.B., Stewart G.R., et al. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem (1996) 271:5953–5956.
[Abstract/Free Full Text] - Vijayaragavan K., O'Leary M.E., Chahine M. Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channels. J Neurosci (2001) 21:7909–7918.
[Abstract/Free Full Text] - Vijayaragavan K., Powell A.J., Kinghorn I.J., Chahine M. Role of auxiliary beta1-, beta2-, and beta3-subunits and their interaction with Na(v)1.8 voltage-gated sodium channel. Biochem Biophys Res Commun (2004) 319:531–540.[CrossRef][Web of Science][Medline]
- Qu Y., Isom L.L., Westenbroek R.E., Rogers J.C., Tanada T.N., McCormick K.A., et al. Modulation of cardiac Na+ channel expression in Xenopus oocytes by β1 subunits. J Biol Chem (1995) 270:25696–25701.
[Abstract/Free Full Text] - Makita N., Bennett P.B. Jr., George A.L. Jr. Voltage-gated Na+ channel β1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J Biol Chem (1994) 269:7571–7578.
[Abstract/Free Full Text] - Yang J.S., Bennett P.B., Makita N., George A.L., Barchi R.L. Expression of the sodium channel β1 subunit in rat skeletal muscle is selectively associated with the tetrodotoxin-sensitive
subunit isoform. Neuron (1993) 11:915–922.[CrossRef][Web of Science][Medline] - Nuss H.B., Chiamvimonvat N., Perez-Garcia M.T., Tomaselli G.F., Marban E. Functional association of the beta 1 subunit with human cardiac (hH1) and rat skeletal muscle (µ1) sodium channel alpha subunits expressed in Xenopus oocytes. J Gen Physiol (1995) 106:1171–1191.
[Abstract/Free Full Text] - Makielski J.C., Limberis J.T., Chang S.Y., Fan Z., Kyle J.W. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block. Mol Pharmacol (1996) 49:30–39.[Abstract]
- An R.H., Wang X.L., Kerem B., Benhorin J., Medina A., Goldmit M., et al. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res (1998) 83:141–146.
[Abstract/Free Full Text] - Ko S.H., Lenkowski P.W., Lee H.C., Mounsey J.P., Patel M.K. Modulation of Na(v)1.5 by beta1- and beta3-subunit co-expression in mammalian cells. Pflugers Arch (2005) 449:403–412.[CrossRef][Web of Science][Medline]
- Fahmi A.I., Patel M., Stevens E.B., Fowden A.L., John J.E. III, Lee K, et al. The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart. J Physiol (2001) 537:693–700.
[Abstract/Free Full Text] - Malhotra J.D., Thyagarajan V., Chen C., Isom L.L. Tyrosine-phosphorylated- and nonphosphorylated-sodium channel β1 subunits are differentially localized in cardiac myocytes. J Biol Chem (2004) 279:40748–40754.
[Abstract/Free Full Text] - Dominguez J.N., Navarro F., Franco D., Thompson R.P., Aranega A.E. Temporal and spatial expression pattern of beta1 sodium channel subunit during heart development. Cardiovasc Res (2005) 65:842–850.
[Abstract/Free Full Text] - Zimmer T., Biskup C., Bollensdorff C., Benndorf K. The beta1 subunit but not the beta2 subunit colocalizes with the human heart Na+ channel (hH1) already within the endoplasmic reticulum. J Membr Biol (2002) 186:13–21.[CrossRef][Web of Science][Medline]
- Rougier J.S., van Bemmelen M.X., Bruce M.C., Jespersen T., Gavillet B., Apotheloz F., et al. Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins. Am J Physiol Cell Physiol (2005) 288:C692–C701.
[Abstract/Free Full Text] - van Bemmelen M.X., Rougier J.S., Gavillet B., Apotheloz F., Daidie D., Tateyama M. Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res (2004) 95:284–291.
[Abstract/Free Full Text] - Blot V., Perugi F., Gay B., Prevost M.C., Briant L., Tangy F., et al. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci (2004) 117:2357–2367.
[Abstract/Free Full Text] - Grieco T.M., Malhotra J.D., Chen C., Isom L.L., Raman I.M. Open-channel block by the cytoplasmic tail of sodium channel β4 as a mechanism for resurgent sodium current. Neuron (2005) 45:233–244.[CrossRef][Web of Science][Medline]
- Yu F.H., Mantegazza M., Westenbroek R., Robbins C.A., Spain W.J., Burton K.A., et al. Deletion of the Nav1.1 channel: a mouse model for severe myoclonic epilepsy of infancy. Abstract viewer/itinerary planner. (2004) Washington, DC: Society for Neuroscience. 5. Program No. 479.
- Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 68:1327–1332.[CrossRef][Web of Science][Medline]
- Papadatos G.A., Wallerstein P.M., Head C.E., Ratcliff R., Brady P.A., Benndorf K., et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A (2002) 99:6210–6215.
[Abstract/Free Full Text] - Escayg A., Heils A., MacDonald B.T., Haug K., Sander T., Meisler M.H. A novel scn1a mutation associated with generalized epilepsy with febrile seizures plus- and prevalence of various patients with epilepsy. Am J Hum Genet (2001) 68:866–873.[CrossRef][Web of Science][Medline]
- Kearney J.A., Buchner D.A., De Haan G., Adamska M., Levin S.I., Furay A.R., et al. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Hum Mol Genet (2002) 11:2765–2775.
[Abstract/Free Full Text] - Sprunger L.K., Escayg A., Tallaksen-Greene S., Albin R.L., Meisler M.H. Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3. Hum Mol Genet (1999) 8:471–479.
[Abstract/Free Full Text] - Hamann M., Meisler M.H., Richter A. Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia. Exp Neurol (2003) 184:830–838.[CrossRef][Web of Science][Medline]
- Yarbrough T.L., Lu T., Lee H.C., Shibata E.F. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res (2002) 90:443–449.
[Abstract/Free Full Text] - Chen C., Bharucha B., Chen Y., Westenbroek R.E., Brown A., Malhotra J.D., et al. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel β2 subunits. Proc Natl Acad Sci U S A (2002) 99:17072–17077.
[Abstract/Free Full Text] - Chen C., Westenbroek R.E., Xu X., Edwards C.A., Sorenson D.R., Chen Y., et al. Mice lacking sodium channel β1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci (2004) 24:4030–4042.
[Abstract/Free Full Text] - Isom L.L. The role of sodium channels in cell adhesion. Front Biosci (2002) 7:12–23.[Web of Science][Medline]
- Srinivasan J., Schachner M., Catterall W.A. Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci U S A (1998) 95:15753–15757.
[Abstract/Free Full Text] - Xiao Z.-C., Ragsdale D.S., Malhorta J.D., Mattei L.N., Braun P.E., Schachner M., et al. Tenascin-R is a functional modulator of sodium channel β subunits. J Biol Chem (1999) 274:26511–26517.
[Abstract/Free Full Text] - Schellings M.W., Pinto Y.M., Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res (2004) 64:24–31.
[Abstract/Free Full Text] - Brümmendorf T., Hubert M., Treubert U., Leuschner R., Tarnok A., Rathjen F.G. The axonal recognition molecule F11 is a multifunctional protein: specific domains mediate interactions with Ng-CAM and restrictin. Neuron (1993) 10:711–727.[CrossRef][Web of Science][Medline]
- Malhotra J.D., Kazen-Gillespie K., Hortsch M., Isom L.L. Sodium channel β subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell–cell contact. J Biol Chem (2000) 275:11383–11388.
[Abstract/Free Full Text] - Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (2003) 421:634–639.[CrossRef][Medline]
- Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S., Priori S.G., et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A (2004) 101:17533–17538.
[Abstract/Free Full Text] - Chauhan V.S., Tuvia S., Buhusi M., Bennett V., Grant A.O. Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice. Circ Res (2000) 86:441–447.
[Abstract/Free Full Text] - Zhou D., Lambert S., Malen P.J., Carpenter S., Boland L.M., Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol (1998) 143:1295–1304.
[Abstract/Free Full Text] - Scotland P., Zhou D., Benveniste H., Bennett V. Nervous system defects of AnkyrinB (–/–) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol (1998) 143:1305–1315.
[Abstract/Free Full Text] - Malhotra J.D., Koopmann M.C., Kazen-Gillespie K.A., Fettman N., Hortsch M., Isom L.L. Structural requirements for interaction of sodium channel β1 subunits with ankyrin. J Biol Chem (2002) 277:26681–26688.
[Abstract/Free Full Text] - McEwen D.P., Meadows L.S., Chen C., Thyagarajan V., Isom L.L. Sodium channel β1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J Biol Chem (2004) 279:16044–16049.
[Abstract/Free Full Text] - McEwen D.P., Isom L.L. Heterophilic interactions of sodium channel beta 1 subunits with axonal and glial cell adhesion molecules. J Biol Chem (2004) 279:52744–52752.
[Abstract/Free Full Text] - Kazarinova-Noyes K., Malhotra J.D., McEwen D.P., Mattei L.N., Berglund E.O., Ranscht B., et al. Contactin associates with Na+ channels and increases their functional expression. J Neurosci (2001) 21:7517–7525.
[Abstract/Free Full Text] - Kazarinova-Noyes K., Shrager P. Molecular constituents of the node of Ranvier. Mol Neurobiol (2002) 26:167–182.[CrossRef][Web of Science][Medline]
- Ratcliffe C.F., Westenbroek R.E., Curtis R., Catterall W.A. Sodium channel beta1 and beta3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J Cell Biol (2001) 154:427–434.
[Abstract/Free Full Text] - Shah B.S., Rush A.M., Liu S., Tyrrell L., Black J.A., Dib-Hajj S.D., et al. Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface. J Neurosci (2004) 24:7387–7399.
[Abstract/Free Full Text] - Liu C.J., Dib-Hajj S.D., Black J.A., Greenwood J., Lian Z., Waxman S.G. Direct interaction with contactin targets voltage-gated sodium channel Na(v)1.9/NaN to the cell membrane. J Biol Chem (2001) 276:46553–46561.
[Abstract/Free Full Text] - Soler A.P., Gilliard G., Xiong Y., Knudsen K.A., Martin J.L., De Suarez C.B., et al. Overexpression of neural cell adhesion molecule in Chagas' myocarditis. Hum Pathol (2001) 32:149–155.[CrossRef][Web of Science][Medline]
- Gattenlohner S., Waller C., Ertl G., Bultmann B.D., Muller-Hermelink H.K., Marx A. NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. Am J Pathol (2003) 163:1081–1090.
[Abstract/Free Full Text] - Ratcliffe C.F., Qu Y., McCormick K.A., Tibbs V.C., Dixon J.E., Scheuer T., et al. A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta. Nat Neurosci (2000) 3:437–444.[CrossRef][Web of Science][Medline]
- Meadows L.S., Malhotra J., Loukas A., Thyagarajan V., Kazen-Gillespie K.A., Koopman M.C., et al. Functional and biochemical analysis of a sodium channel β1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci (2002) 22:10699–10709.
[Abstract/Free Full Text] - Jenkins S.M., Kizhatil K., Kramarcy N.R., Sen A., Sealock R., Bennett V. FIGQY phosphorylation defines discrete populations of L1 cell adhesion molecules at sites of cell–cell contact and in migrating neurons. J Cell Sci (2001) 114:3823–3835.
[Abstract/Free Full Text] - Zhang X., Davis J.Q., Carpenter S., Bennett V. Structural requirements for association of neurofascin with ankyrin. J Biol Chem (1998) 273:30785–30794.
[Abstract/Free Full Text] - Garver T.D., Ren Q., Tuvia S., Bennett V. Tyrosine phosphorylation at a site highly conserved in the L1 family of cell adhesion molecules abolishes ankyrin binding and increases lateral mobility of neurofascin. J Cell Biol (1997) 137:703–714.
[Abstract/Free Full Text] - Tuvia S., Garver T.D., Bennett V. The phosphorylation state of the FIGQY tyrosine of neurofascin determines ankyrin-binding activity and patterns of cell segregation. Proc Natl Acad Sci U S A (1997) 94:12957–12962.
[Abstract/Free Full Text] - Chen L., Ong B., Bennett V. LAD-1, the Caenorhabditis elegans L1CAM homologue, participates in embryonic and gonadal morphogenesis and is a substrate for fibroblast growth factor receptor pathway-dependent phosphotyrosine-based signaling. J Cell Biol (2001) 154:841–855.
[Abstract/Free Full Text] - Brette F., Orchard C. T-tubule function in mammalian cardiac myocytes. Circ Res (2003) 92:1182–1192.
[Abstract/Free Full Text] - Sinn H.W., Balsamo J., Lilien J., Lin J.J. Localization of the novel Xin protein to the adherens junction complex in cardiac and skeletal muscle during development. Dev Dyn (2002) 225:1–13.[CrossRef][Web of Science][Medline]
- Peters N.S., Severs N.J., Rothery S.M., Lincoln C., Yacoub M.H., Green C.R. Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation (1994) 90:713–725.
[Abstract/Free Full Text] - Kostin S., Hein S., Bauer E.P., Schaper J. Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res (1999) 85:154–167.
[Abstract/Free Full Text] - Lilien J., Balsamo J., Arregui C., Xu G. Turn-off, drop-out: functional state switching of cadherins. Dev Dyn (2002) 224:18–29.[CrossRef][Web of Science][Medline]
- Maltsev V.A., Undrovinas A.I. Cytoskeleton modulates coupling between availability and activation of cardiac sodium channel. Am J Physiol (1997) 273:H1832–H1840.[Web of Science][Medline]
- Undrovinas A.I., Shander G.S., Makielski J.C. Cytoskeleton modulates gating of voltage-dependent sodium channel in heart. Am J Physiol (1995) 269:H203–H214.[Web of Science][Medline]
- Ou Y., Strege P., Miller S.M., Makielski J., Ackerman M., Gibbons S.J., et al. Syntrophin gamma 2 regulates SCN5A gating by a PDZ domain-mediated interaction. J Biol Chem (2003) 278:1915–1923.
[Abstract/Free Full Text] - Barker R.J., Price R.L., Gourdie R.G. Increased co-localization of connexin43 and ZO-1 in dissociated adult myocytes. Cell Commun Adhes (2001) 8:205–208.[Web of Science][Medline]
- Barker R.J., Price R.L., Gourdie R.G. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res (2002) 90:317–324.
[Abstract/Free Full Text] - Zimmer T., Benndorf K. The human heart and rat brain IIA Na(+) channels interact with different molecular regions of the beta(1) subunit. J Gen Physiol (2002) 120:887–895.
[Abstract/Free Full Text] - Spampanato J., Kearney J.A., De Haan G., McEwen D.P., Escayg A., Aradi I., et al. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J Neurosci (2004) 24:10022–10034.
[Abstract/Free Full Text] - Jentsch T.J., Hubner C.A., Fuhrmann J.C. Ion channels: function unravelled by dysfunction. Nat Cell Biol (2004) 6:1039–1047.[CrossRef][Web of Science][Medline]
- Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 41:171–174.
[Abstract/Free Full Text] - Wallace R.H., Wang D.W., Singh R., Scheffer I.E., George A.L. Jr., Phillips H.A., et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 19:366–370.[CrossRef][Web of Science][Medline]
- Audenaert D., Claes L., Ceulemans B., Lofgren A., Van Broeckhoven C., De Jonghe P. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology (2003) 61:854–856.
[Abstract/Free Full Text] - Wan X., Wang Q., Kirsch G.E. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation. J Mol Cell Cardiol (2000) 32:1873–1884.[CrossRef][Web of Science][Medline]
- Abbott G.W., Goldstein S.A.N. A superfamily of small potassium channel subunits: form and function of the MinK-related peptides (MiRPs). Q Rev Biophys (1998) 31:357–398.[CrossRef][Web of Science][Medline]
- Wei J., Wang D.W., Alings M., Fish F., Wathen M., Roden D.M., et al. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel [in process citation]. Circulation (1999) 99:3165–3171.
[Abstract/Free Full Text] - Qu Y., Rogers J.C., Chen S.F., McCormick K.A., Scheuer T., Catterall W.A. Functional roles of the extracellular segments of the sodium channel alpha subunit in voltage-dependent gating and modulation by beta1 subunits. J Biol Chem (1999) 274:32647–32654.
[Abstract/Free Full Text] - McCormick K.A., Srinivasan J., White K., Scheuer T., Catterall W.A. The extracellular domain of the beta1 subunit is both necessary and sufficient for beta1-like modulation of sodium channel gating. J Biol Chem (1999) 274:32638–32646.
[Abstract/Free Full Text] - Meadows L.S., Chen C., Speelman A.I., Malhotra J.D., Isom L.L. Characterization of cardiac sodium channel function in β1 subunit null mice. In: Abstract viewer/itinerary planner (2004) Washington, DC: Society for Neuroscience. Program No. 262.9. 2004.
- Kaab S., Dixon J., Duc J., Ashen D., Nabauer M., Beuckelmann D.J., et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation (1998) 98:1383–1393.
[Abstract/Free Full Text] - Deschenes I., Tomaselli G.F. Modulation of Kv4.3 current by accessory subunits. FEBS Lett (2002) 528:183–188.[CrossRef][Web of Science][Medline]
- Deschenes I., Armoundas A.A., Jones S.P., Poelzing S., Tomaselli G.F. Functional link between Na channels and Ito revealed by posttranscriptional gene silencing of Nav-beta1 in cardiac myocytes. AHA Sci Sess (Abstr) (2004) (283).
- Deschenes I., Armoundas A.A., Jones S.P., Tomaselli G.F. Post-transcriptional gene silencing of KChIP2 in cardiac myocytes suggests a structural and developmental link between Ito and Na channel. AHA Sci Sess (Abstr) (2003) 234.
- Lemaillet G., Walker B., Lambert S. Identification of a conserved ankyrin-binding motif in the family of sodium channel alpha subunits. J Biol Chem (2003) 278:27333–27339.
[Abstract/Free Full Text] - Mohler P.J., Splawski I., Napolitano C., Bottelli G., Sharpe L., Timothy K., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A (2004) 101:9137–9142.
[Abstract/Free Full Text] - Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature (1990) 345:315–319.[CrossRef][Medline]
- Gee S.H., Madhavan R., Levinson S.R., Caldwell J.H., Sealock R., Froehner S.C. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci (1998) 18:128–137.
[Abstract/Free Full Text] - Leonoudakis D., Conti L.R., Anderson S., Radeke C.M., McGuire L.M., Adams M.E., et al. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J Biol Chem (2004) 279:22331–22346.
[Abstract/Free Full Text] - Westenbroek R.E., Merrick D.K., Catterall W.A. Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons. Neuron (1989) 3:695–704.[CrossRef][Web of Science][Medline]
- Furuyama T., Morita Y., Inagaki S., Takagi H. Distribution of I, II and III subtypes of voltage-sensitive Na+ channel mRNA in the rat brain. Brain Res Mol Brain Res (1993) 17:169–173.[Medline]
- Schaller K.L., Krzemien D.M., Yarowsky P.J., Krueger B.K., Caldwell J.H. A novel, abundant sodium channel expressed in neurons and glia. J Neurosci (1995) 15:3231–3242.[Abstract]
- Barry D.M., Trimmer J.S., Merlie J.P., Nerbonne J.M. Differential expression of voltage-gated K+ channel subunits in adult rat heart. Relation to functional K+ channels? Circ Res (1995) 77:361–369.
[Abstract/Free Full Text] - Takeuchi S., Takagishi Y., Yasui K., Murata Y., Toyama J., Kodama I. Voltage-gated K(+)Channel, Kv4.2, localizes predominantly to the transverse-axial tubular system of the rat myocyte. J Mol Cell Cardiol (2000) 32:1361–1369.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
C. A. Remme, B. P. Scicluna, A. O. Verkerk, A. S. Amin, S. van Brunschot, L. Beekman, V. H.M. Deneer, C. Chevalier, F. Oyama, H. Miyazaki, et al. Genetically Determined Differences in Sodium Current Characteristics Modulate Conduction Disease Severity in Mice With Cardiac Sodium Channelopathy Circ. Res., June 5, 2009; 104(11): 1283 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, D. Darbar, D. W. Kaiser, K. Jiramongkolchai, S. Chopra, B. S. Donahue, P. J. Kannankeril, and D. M. Roden Mutations in Sodium Channel {beta}1- and {beta}2-Subunits Associated With Atrial Fibrillation Circ Arrhythmia Electrophysiol, June 1, 2009; 2(3): 268 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hu, H. Barajas-Martinez, E. Burashnikov, M. Springer, Y. Wu, A. Varro, R. Pfeiffer, T. T. Koopmann, J. M. Cordeiro, A. Guerchicoff, et al. A Mutation in the {beta}3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype Circ Cardiovasc Genet, June 1, 2009; 2(3): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Aman, T. M. Grieco-Calub, C. Chen, R. Rusconi, E. A. Slat, L. L. Isom, and I. M. Raman Regulation of Persistent Na Current by Interactions between {beta} Subunits of Voltage-Gated Na Channels J. Neurosci., February 18, 2009; 29(7): 2027 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Brackenbury, M. B.A. Djamgoz, and L. L. Isom An Emerging Role for Voltage-Gated Na+ Channels in Cellular Migration: Regulation of Central Nervous System Development and Potentiation of Invasive Cancers Neuroscientist, December 1, 2008; 14(6): 571 - 583. [Abstract] [PDF] |
||||
![]() |
M. A. Stagg, E. Carter, N. Sohrabi, U. Siedlecka, G. K. Soppa, F. Mead, N. Mohandas, P. Taylor-Harris, A. Baines, P. Bennett, et al. Cytoskeletal Protein 4.1R Affects Repolarization and Regulates Calcium Handling in the Heart Circ. Res., October 10, 2008; 103(8): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Cordeiro, M. Mazza, R. Goodrow, N. Ulahannan, C. Antzelevitch, and J. M. Di Diego Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H154 - H162. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, C. F. Browning, H. Hallaq, L. Yermalitskaya, J. Esker, M. R. Hall, A. J. Link, A.-J. L. Ham, M. J. McGrath, C. A. Mitchell, et al. Four and a half LIM protein 1: a partner for KCNA5 in human atrium Cardiovasc Res, June 1, 2008; 78(3): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev, V. Reznikov, N. A. Undrovinas, H. N. Sabbah, and A. Undrovinas Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1597 - H1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Brackenbury, T. H. Davis, C. Chen, E. A. Slat, M. J. Detrow, T. L. Dickendesher, B. Ranscht, and L. L. Isom Voltage-Gated Na+ Channel {beta}1 Subunit-Mediated Neurite Outgrowth Requires Fyn Kinase and Contributes to Postnatal CNS Development In Vivo J. Neurosci., March 19, 2008; 28(12): 3246 - 3256. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5 J. Biol. Chem., March 14, 2008; 283(11): 6968 - 6978. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Casini, H. L. Tan, Z. A. Bhuiyan, C. R. Bezzina, P. Barnett, E. Cerbai, A. Mugelli, A. A.M. Wilde, and M. W. Veldkamp Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation Cardiovasc Res, December 1, 2007; 76(3): 418 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin, R. Otway, and J. I. Vandenberg Genes and Atrial Fibrillation: A New Look at an Old Problem Circulation, August 14, 2007; 116(7): 782 - 792. [Full Text] [PDF] |
||||
![]() |
A. Medeiros-Domingo, T. Kaku, D. J. Tester, P. Iturralde-Torres, A. Itty, B. Ye, C. Valdivia, K. Ueda, S. Canizales-Quinteros, M. T. Tusie-Luna, et al. SCN4B-Encoded Sodium Channel 4 Subunit in Congenital Long-QT Syndrome Circulation, July 10, 2007; 116(2): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Cordeiro, H. Barajas-Martinez, K. Hong, E. Burashnikov, R. Pfeiffer, A.-M. Orsino, Y. S. Wu, D. Hu, J. Brugada, P. Brugada, et al. Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome Circulation, November 7, 2006; 114(19): 2026 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Lopez-Santiago, M. Pertin, X. Morisod, C. Chen, S. Hong, J. Wiley, I. Decosterd, and L. L. Isom Sodium channel beta2 subunits regulate tetrodotoxin-sensitive sodium channels in small dorsal root ganglion neurons and modulate the response to pain. J. Neurosci., July 26, 2006; 26(30): 7984 - 7994. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden The molecular genetics of arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 343 - 346. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









